Mitochondrial and nuclear genes as the cause of complex I deficiency
A R Rezaee1, A Azadi, M Houshmand
1Animal Science Department, College of Agriculture, Ferdowsi University of Mashhad, Mashhad, Iran.
Abstract:
Multiple sclerosis (MS) is an immunological inflammatory disease of the central nervous system. The pathogenesis of MS is incompletely understood, but various studies have suggested that mitochondrial dysfunction is associated with the disease. Mitochondria are among the main cellular sources of reactive oxygen and nitrogen species, and they play a pivotal role in many neuro-pathological conditions. The mitochondrial nuclear subunit of complex I gene in mitochondria may play a role in MS, and understanding this role may provide rationale for novel approaches to treatment of the disease and the development of novel therapies. We designed a molecular study to demonstrate biochemical defects in complex I activity and found some novel nucleotide substitutions in mitochondrial DNA that might be involved in the pathogenesis of MS. The mitochondrial complex subunit I sequence was amplified and sequenced in MS patients. Although no reported pathogenic mutations were found in these patients, other studies have clearly indicated that the mitochondrial nuclear complex subunit I gene plays a significant role in MS pathogenesis.
Insights
Mitochondrial dysfunction, particularly in complex I, is linked to multiple sclerosis (MS) pathogenesis. This study identified novel mitochondrial DNA variations in MS patients, suggesting a role in the disease, though no known pathogenic mutations were found.
Area of Science:
- Neuroimmunology
- Mitochondrial Biology
- Genetics
Background:
- Multiple sclerosis (MS) is an inflammatory central nervous system disease with incompletely understood pathogenesis.
- Mitochondrial dysfunction is increasingly implicated in neurodegenerative and neuro-inflammatory conditions.
- Mitochondria are key producers of reactive oxygen and nitrogen species, influencing cellular health.
Purpose of the Study:
- To investigate the role of mitochondrial complex I gene variations in the pathogenesis of multiple sclerosis.
- To identify potential biochemical defects in complex I activity in MS patients.
- To explore novel therapeutic targets based on mitochondrial involvement in MS.
Main Methods:
- Molecular study involving amplification and sequencing of the mitochondrial complex subunit I gene in MS patients.
- Biochemical analysis to assess complex I activity.
- Analysis of mitochondrial DNA for nucleotide substitutions.
Main Results:
- Novel nucleotide substitutions in mitochondrial DNA were identified in MS patients.
- No previously reported pathogenic mutations in the mitochondrial complex subunit I gene were found in the studied MS cohort.
- Biochemical defects in complex I activity were demonstrated.
Conclusions:
- The study suggests that mitochondrial complex I gene variations may contribute to the pathogenesis of multiple sclerosis.
- Identified nucleotide substitutions warrant further investigation for their role in MS.
- Understanding mitochondrial involvement offers potential for developing novel MS therapies.
Related Concept Videos
ATP Synthase: Mechanism
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Animal Mitochondrial Genetics
Electron Transport Chain: Complex III and IV
Mitochondrial Precursor Proteins
Most of the mitochondrial precursors...
The Supercomplexes in the Crista Membrane


